SECreport

Form 4 PIERIS PHARMACEUTICALS, For: Jul 25 Filed by: Richman Michael

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com